Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study

Area of Science:

• Hematology
• Infectious Diseases
• Critical Care Medicine

Background:

• Gram-negative septicemia is a life-threatening condition, particularly in patients with granulocytopenia (low granulocyte counts).
• Standard antibiotic therapy may be insufficient for patients with severe granulocytopenia.
• Granulocyte transfusions are a potential adjunctive therapy to combat infection in these vulnerable patients.

Purpose of the Study:

• To evaluate the efficacy of granulocyte transfusions as an adjunct to antibiotic therapy in patients with gram-negative septicemia and granulocytopenia.
• To determine if granulocyte transfusions improve survival rates in this patient population.

Main Methods:

• A prospective randomized trial involving 27 granulocytopenic patients with 30 episodes of gram-negative septicemia.
• Patients were randomized to receive either appropriate antibiotic regimen alone (control group) or antibiotics plus granulocyte transfusions (transfusion group).
• Survival rates and the impact of bone marrow recovery on outcomes were analyzed.

Main Results:

• The survival rate in the transfusion group (12 of 16) was significantly higher than in the control group (5 of 14) (P < 0.04).
• Survival was strongly associated with bone marrow recovery (granulocyte count ≥1000/µL).
• In patients with persistent granulocytopenia, 67% in the transfusion group survived compared to 0% in the control group (P < 0.005).

Conclusions:

• Granulocyte transfusions, when combined with appropriate antibiotics, significantly improve survival in patients with gram-negative septicemia and granulocytopenia.
• The benefit of granulocyte transfusions is particularly evident in patients who do not experience bone marrow recovery.
• Granulocyte transfusions represent a valuable therapeutic option to complement antibiotic treatment for severe gram-negative infections in granulocytopenic patients.